Phagocytosis removes pathogens and tissue debris during inflammatory reacti
ons, but also plays an important role in autoimmune reactions. The main pha
gocytes in the central nervous system (CNS) are microglial cells that are a
ctivated during CNS inflammation. In the treatment of inflammatory demyelin
ating diseases like multiple sclerosis (MS), administration of intravenous
immunoglobulins (IVIg) has become a promising immunomodulatory therapy. Alt
hough a large number of potential mechanisms for the effects of IVIg has be
en suggested, the precise mode of action in CNS inflammation is unknown. We
assessed the influence of IVIg on phagocytosis and endocytosis in microgli
a in vitro. IVIg had little effect on non-specific phagocytosis of latex pa
rticles in untreated microglia, while there was a dose-dependent inhibition
in microglia activated with LPS and IFN gamma. Endocytosis of soluble myel
in basic protein (MBP) was downregulated by IVIg in both untreated and acti
vated microglia. The effect was mediated by an F(ab')(2) preparation of imm
unoglobulins, suggesting that Fc receptor-mediated phagocytosis is not invo
lved. Intact IVIg, bur not F(ab')(2) fragments also suppressed Fc receptor-
mediated phagocytosis of opsonised erythrocytes in both untreated and activ
ated microglia. These results show that IVIg can inhibit the phagocytic act
ivity of microglia via different mechanisms. Such an effect could contribut
e to the immunomodulatory capacity of IVIg in inflammatory CNS diseases. (C
) 2000 Elsevier Science B.V. All rights reserved.